Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Musiol

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Current Pharmaceutical Design|October 25, 2012
Quinoline-based HIV integrase inhibitorsRobert Musiol
Expert Opinion on Drug Discovery|April 13, 2017
An overview of quinoline as a privileged scaffold in cancer drug discoveryRobert Musiol
Expert Opinion on Therapeutic Targets|October 3, 2023
Efflux systems as a target for anti-biofilm nanoparticles: perspectives on emerging applicationsRobert Musiol
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 5, 2019
Styrylquinoline - A Versatile Scaffold in Medicinal ChemistryRobert Musiol
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 4, 2017
Quinoline Fluorescent Probes for Zinc - from Diagnostic to Therapeutic Molecules in Treating Neurodegenerative DiseasesBarbara Czaplinska, Ewelina Spaczynska, Robert Musiol
Current Pharmaceutical Design|November 15, 2011
Prodrugs in photodynamic anticancer therapyRobert Musiol, Maciej Serda, Jaroslaw Polanski
Expert Opinion on Drug Discovery|December 20, 2021
Terpyridines as promising antitumor agents: an overview of their discovery and developmentRobert Musiol, Patryk Malecki, Marcin Pacholczyk, et al.
European Journal of Medicinal Chemistry|December 19, 2018
The p53 stabilizing agent CP-31398 and multi-kinase inhibitors. Designing, synthesizing and screening of styrylquinazoline seriesJacek Mularski, Katarzyna Malarz, Marcin Pacholczyk, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|April 18, 2023
Styrylquinazoline derivatives as ABL inhibitors selective for different DFG orientationsKatarzyna Malarz, Jacek Mularski, Marcin Pacholczyk, et al.
Cancers|March 1, 2020
The Landscape of the Anti-Kinase Activity of the IDH1 InhibitorsKatarzyna Malarz, Jacek Mularski, Marcin Pacholczyk, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Current Pharmaceutical Design|October 25, 2012
Quinoline-based HIV integrase inhibitorsRobert Musiol
Expert Opinion on Drug Discovery|April 13, 2017
An overview of quinoline as a privileged scaffold in cancer drug discoveryRobert Musiol
Expert Opinion on Therapeutic Targets|October 3, 2023
Efflux systems as a target for anti-biofilm nanoparticles: perspectives on emerging applicationsRobert Musiol
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 5, 2019
Styrylquinoline - A Versatile Scaffold in Medicinal ChemistryRobert Musiol
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 4, 2017
Quinoline Fluorescent Probes for Zinc - from Diagnostic to Therapeutic Molecules in Treating Neurodegenerative DiseasesBarbara Czaplinska, Ewelina Spaczynska, Robert Musiol
Current Pharmaceutical Design|November 15, 2011
Prodrugs in photodynamic anticancer therapyRobert Musiol, Maciej Serda, Jaroslaw Polanski
Expert Opinion on Drug Discovery|December 20, 2021
Terpyridines as promising antitumor agents: an overview of their discovery and developmentRobert Musiol, Patryk Malecki, Marcin Pacholczyk, et al.
European Journal of Medicinal Chemistry|December 19, 2018
The p53 stabilizing agent CP-31398 and multi-kinase inhibitors. Designing, synthesizing and screening of styrylquinazoline seriesJacek Mularski, Katarzyna Malarz, Marcin Pacholczyk, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|April 18, 2023
Styrylquinazoline derivatives as ABL inhibitors selective for different DFG orientationsKatarzyna Malarz, Jacek Mularski, Marcin Pacholczyk, et al.
Cancers|March 1, 2020
The Landscape of the Anti-Kinase Activity of the IDH1 InhibitorsKatarzyna Malarz, Jacek Mularski, Marcin Pacholczyk, et al.
Pageof 6